Actively Recruiting
MRgFUS and RFA for Treatment of Facet-joint Osteoarthritis Low Back Pain
Led by Taipei Medical University Hospital · Updated on 2024-12-05
100
Participants Needed
1
Research Sites
378 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, randomized, two-arm, phase II study. The purpose of this study is: * To evaluate and compare the efficacy and safety of magnetic resonance-guided focused ultrasound (MRgFUS) and radiofrequency ablation (RFA) for treatment of facet-joint osteoarthritis low back pain. * Determining the effect of the MRgFUS System and RFA for improving functional disabilities and in reducing pain resulting from facet-joint osteoarthritis low back pain. Efficacy will be determined by the level of pain relief (as measured by the Numerical Rating Scale, NRS), decrease in analgesics/opiate, improved quality of life (as measured by the Oswestry Disability Questionnaire, ODQ, and core outcome measures index questionnaire, COMI), pain interference with function (as measured by the Brief Pain Inventory-Interference scale, BPI-QoL), general health status (as measured by the EQ5D), physical exam, X-ray and MRI studies from baseline up to 12-Months post- MRgFUS and radiofrequency treatment. * Evaluate incidence and severity of adverse events associated with the MRgFUS system and RFA used for the treatment of pain resulting from facet-joint osteoarthritis low back pain.
CONDITIONS
Official Title
MRgFUS and RFA for Treatment of Facet-joint Osteoarthritis Low Back Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women age 20 to 79 years old
- Diagnosed with lumbar vertebral facet joint syndrome
- Have had lower back pain for at least six months with a pain score of 4 or higher on the Numerical Rating Scale
- Have tried conventional pain treatments such as NSAIDs, opioids, muscle relaxants, oral steroids, physical therapy, or chiropractic therapy
- Imaging shows facet osteoarthritis in the spine
- Referred pain does not extend below the knee
- Experienced at least 75% pain relief from local anesthesia or diagnostic medial nerve branch injection with 0.5ml of 2% lidocaine
You will not qualify if you...
- Evidence of lumbosacral radiculopathy on MRI, CT, or physical exam, including radicular leg pain
- Presence of motor deficits or any need for surgical intervention
- Received MRgFUS or radiofrequency treatment for low back pain within the last 6 months
- Previous low back surgery
- Pregnancy
- Existing malignancy
- Allergies to relevant contrast agents, anesthetics, or sedation drugs
- Contraindications for MRI
- Acute medical conditions such as pneumonia or sepsis that may prevent study completion
- Unstable cardiac conditions including unstable angina on medication, myocardial infarction within 40 days, severe congestive heart failure (NYHA class 4), use of anti-arrhythmic drugs, uncontrolled arrhythmia, or pacemaker
- Severe cerebrovascular disease (stroke within last 6 months)
- Severe hypertension with diastolic blood pressure over 100 despite medication
- Active infections or severe uncontrolled hematological, neurological, or other diseases
- Inability to communicate with study staff
- Unable or unwilling to tolerate approximately 2 hours in a stationary position during treatment
- Coagulation or bleeding disorders, or use of anticoagulants or antiplatelet drugs within 5 days before treatment
- Less than 75% pain relief following local anesthesia or diagnostic medial nerve branch injection with 0.5ml of 2% lidocaine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Taipei medical university hospital
Taipei, Please Select, Taiwan, 11031
Actively Recruiting
Research Team
M
Meng-Huang Wu, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here